Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hydroxocobalamin chloride injection - CSPC ZhongQi Pharmaceutical Technology

Next Previous
Drug Profile

Hydroxocobalamin chloride injection - CSPC ZhongQi Pharmaceutical Technology

Alternative Names: Hydroxocobalamin chloride - CSPC ZhongQi Pharmaceutical Technology

Latest Information Update: 30 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CSPC ZhongQi Pharmaceutical Technology
  • Class Corrinoids; Vitamin B12 analogues; Vitamins
  • Mechanism of Action Nitric oxide inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Methylmalonic acidaemia

Most Recent Events

  • 16 Sep 2025 CSPC ZhongQi Pharmaceutical Technology plans a phase III trial for Methylmalonic acidemia (In Infants, In Children, In adolescents, In adults) in August 2025 (Parenteral, Injection) (NCT07163364)
  • 09 Sep 2025 Preclinical trials in Methylmalonic acidaemia in China (Parenteral)
  • 03 Jul 2025 CSPC ZhongQi Pharmaceutical receives approval from the National Medical Products Administration of China to conduct clinical trials in methylmalonic acidemia in China

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top